Literature DB >> 7229035

Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

M J Malloy, J P Kane, D A Hardman, R L Hamilton, K B Dalal.   

Abstract

In the two genetic forms of abetalipoproteinemia described previously, recessive abetalipoproteinemia and homozygous hypobetalipoproteinemia, all lipoproteins that normally contain apolipoprotein B are absent from plasma. We describe here a new disorder in which normal low density and very low density lipoproteins are absent, but in which triglycerides are absorbed from the intestine and chylomicrons are present in plasma. The underlying molecular defect appears to be selective deletion of the hepatogenous B-100 apolipoprotein. The B-48 apolipoprotein found in chylomicrons is spared. These findings suggest that the two species of apolipoprotein B are under separate genetic control and that low density lipoproteins are not normally derived from chylomicrons.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7229035      PMCID: PMC370711          DOI: 10.1172/jci110173

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  QUANTITATIVE DETERMINATION OF PLASMA FREE FATTY ACIDS AND TRIGLYCERIDES BY THIN-LAYER CHROMATOGRAPHY.

Authors:  G SCHLIERF; P WOOD
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  New protein in human blood plasma, rich in proline, with lipid-binding properties.

Authors:  T Sata; R J Havel; L Kotite; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

3.  The genetic relationship of abetalipoproteinemia and hypobetalipoproteinemia: a report of the occurence of both diseases within the same family.

Authors:  J J Biemer; R E McCammon
Journal:  J Lab Clin Med       Date:  1975-04

4.  Familial homozygous hypobetalipoproteinemia.

Authors:  C Cottrill; C J Glueck; V Leuba; F Millett; D Puppione; W V Brown
Journal:  Metabolism       Date:  1974-08       Impact factor: 8.694

5.  Investigation of serum lipoproteins and apoproteins in abetalipoproteinaemia.

Authors:  G Kostner; A Holasek; H G Bohlmann; H Thiede
Journal:  Clin Sci Mol Med       Date:  1974-04

Review 6.  Abetalipoproteinemia.

Authors:  H J Kayden
Journal:  Annu Rev Med       Date:  1972       Impact factor: 13.739

Review 7.  Application of electron microscopy to the study of plasma lipoprotein structure.

Authors:  T Forte; A V Nichols
Journal:  Adv Lipid Res       Date:  1972

8.  Vitamin E therapy in abetalipoproteinaemia.

Authors:  D R Muller; J T Harries; J K Lloyd
Journal:  Arch Dis Child       Date:  1970-10       Impact factor: 3.791

9.  Apoprotein composition of very low density lipoproteins of human serum.

Authors:  J P Kane; T Sata; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

View more
  32 in total

Review 1.  Mechanisms for the prevention of vitamin E excess.

Authors:  Maret G Traber
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

2.  Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease.

Authors:  M E Bouma; I Beucler; L P Aggerbeck; R Infante; J Schmitz
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 4.  Apolipoproteins in lipid transport, an impressionist view.

Authors:  D W Erkelens
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

5.  Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.

Authors:  K J Lackner; J C Monge; R E Gregg; J M Hoeg; T J Triche; S W Law; H B Brewer
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 6.  Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers.

Authors:  Noel Peretti; Agnès Sassolas; Claude C Roy; Colette Deslandres; Mathilde Charcosset; Justine Castagnetti; Laurence Pugnet-Chardon; Philippe Moulin; Sylvie Labarge; Lise Bouthillier; Alain Lachaux; Emile Levy
Journal:  Orphanet J Rare Dis       Date:  2010-09-29       Impact factor: 4.123

7.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.

Authors:  D A Hardman; C R Pullinger; R L Hamilton; J P Kane; M J Malloy
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology.

Authors:  G M Berger; G Brown; H E Henderson; F Bonnici
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

10.  Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.

Authors:  S G Young; S J Bertics; L K Curtiss; B W Dubois; J L Witztum
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.